Back |
home / stock / jspr / jspr message board
Subject | By | Source | When |
---|---|---|---|
Does not look good | Docstemcell2020 | investorshub | 01/14/2022 7:26:36 PM |
znewcar1: JSPR 17% v1,3M c9.99 f37,8M H10.69 | znewcar1 | investorshangout | 12/10/2021 2:51:08 AM |
S-1 filing has warrant info: | pcjockey | investorshub | 12/09/2021 1:21:20 AM |
Anyone here have any of the warrants--could not | theswordman | investorshub | 11/15/2021 7:07:23 AM |
#$JSPR back to $14 plus very soon, credit | ZipCash | investorshub | 11/10/2021 4:32:30 PM |
Bounce back north is imminent ! Scooping | ZipCash | investorshub | 10/27/2021 11:04:40 PM |
Absolutely! Its gonna pop soon | ipo_dude | investorshub | 10/21/2021 6:33:17 AM |
With a low float like this and forward | DOA | investorshub | 10/19/2021 7:04:53 PM |
Now a bagholder lol. They pumped it and | Roadtojourney | investorshub | 10/18/2021 8:09:06 PM |
znewcar1: JSPR 31% v35,7M c16.42 f36,5M H18.88 | znewcar1 | investorshangout | 10/18/2021 2:39:31 AM |
Break of $20 this monday imo. | ZipCash | investorshub | 10/16/2021 9:08:15 PM |
18.55 | crudeoil24 | investorshub | 10/15/2021 7:29:35 PM |
Theres fireworks going on and so much quiet | Roadtojourney | investorshub | 10/15/2021 7:23:27 PM |
znewcar1: morning gap up and fade now has vol >$17 | znewcar1 | investorshangout | 10/15/2021 7:21:25 PM |
Weeee | Roadtojourney | investorshub | 10/15/2021 7:12:46 PM |
Yup! | crudeoil24 | investorshub | 10/15/2021 1:23:56 PM |
WOW $JSPR BEAST double top was around | TheFinalCD | investorshub | 10/15/2021 1:23:30 PM |
BOOOOOOOMMMM!!!! | crudeoil24 | investorshub | 10/15/2021 1:23:29 PM |
znewcar1: JSPR 105% v91,7M c14.79 f36,5M H18.24 | znewcar1 | investorshangout | 10/13/2021 8:05:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Jasper Therapeutics Inc. Company Name:
JSPR Stock Symbol:
NASDAQ Market:
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company ...
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous...
REDWOOD CITY, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on deve...